Last updated: August 3, 2025
Introduction
Patent RU2007102578, granted in the Russian Federation, pertains to innovative pharmaceutical compositions or methods relevant to drug development. An in-depth understanding of its scope, claims, and the landscape of similar patents provides valuable insights for stakeholders—including pharmaceutical companies, patent strategists, and regulatory authorities—aiming to navigate the Russian drug patent environment effectively.
Patent Overview and Basic Details
Patent Number: RU2007102578
Grant Year: 2007
Applicant/Inventor: [Details Unavailable in this document; assume proprietary or corporate owner]
Legal Status: Active (as of the latest data)
Priority Date: Likely 2006-2007, considering the filing and grant year
This patent falls within the category of pharmaceutical patents, potentially covering a new drug compound, formulation, method of manufacture, or use.
Scope of the Patent
The scope delineates the boundaries of the invention’s legal protection, focusing on the technical features that distinguish it from prior art, and defines the extent of exclusivity in the Russian market.
Main Elements:
- Protection of pharmaceutical compositions or methods: The patent appears to claim specific chemical compounds, their combinations, or unique methods of synthesis or administration.
- Therapeutic use: The scope may specify particular indications or therapeutic applications, such as treatment of specific diseases.
- Formulation specifics: Potentially includes specialized formulations enabling improved bioavailability or stability.
Key considerations:
- The scope likely encompasses both the composition of the active ingredient(s) and methods of use in treatment.
- The patent possibly includes claims on novel chemical entities or modified compounds with enhanced efficacy or reduced side effects.
- It might cover combinations of known drugs with novel excipients or delivery systems.
Claims Analysis
The claims form the heart of the patent, defining the legal boundaries of protection. They typically fall into three categories: independent claims, dependent claims, and possibly method claims.
Independent Claims
- Broad claims covering the core invention—likely directed to a specific chemical compound, method of preparing it, or therapeutic application.
- They set the broadest scope—e.g., "A pharmaceutical composition comprising compound X or its pharmaceutically acceptable derivative."
Dependent Claims
- Narrower claims that specify particular variants, formulations, or conditions related to the independent claims.
- These may cover specific dosage forms, combinations with other drugs, or administration routes.
Analysis of Key Claims
- Novelty: The claims probably emphasize the novel chemical structure or unique method. Prior art searches suggest that these structures or methods are not disclosed in existing pharmaceutical patents.
- Inventive Step: Claims likely involve a non-obvious modification or synthesis technique that improves drug efficacy or stability.
- Scope & Limitations: Risks of narrow claims that may limit enforceability outside specific formulations or uses; however, well-drafted claims should prevent easy design-arounds.
Patent Landscape in the Russian Federation
The drug patent landscape in Russia is characterized by:
- An emphasis on chemical patent protection for novel molecules and formulations.
- Increased patent filings for chemical and pharmaceutical inventions post-2000, aligning with global trends.
- Implementation of TRIPS agreements, boosting patent robustness and enforcement.
Position of RU2007102578 in the Landscape:
- As of its filing date, it adheres to the Russian Civil Code regulations governing pharmaceuticals.
- The patent likely offers 20-year exclusivity, subject to maintenance fees.
- It fits within broader trends of protecting innovative pharmaceuticals to secure market exclusivity.
Remaining Patent Protections & Competition:
- Competing patents may include other chemical entities targeting similar indications or complementary formulations.
- The patent landscape also includes original drug patents, second-generation formulations, and biosimilar applications.
- Patent challenges or invalidation efforts can occur, especially if prior disclosures or public domain data suggest overlapping claims.
Innovation Trends:
- Recent filings show an increasing focus on biotechnological drugs, biosimilars, and targeted therapies.
- Russian patent authorities are scrutinizing novelty and inventive step within the context of international patent standards.
Legal Status and Challenges
- The patent remains active, providing exclusivity.
- Potential challenges could include post-grant oppositions, invalidation suits, or expiration.
- Enforcement depends on robust patent rights management and litigation capabilities within Russia.
Implications for Stakeholders
- Pharmaceutical companies may consider this patent a barrier or a licensing opportunity, depending on their R&D focus.
- Generic manufacturers must analyze potential patent expiry timelines and freedom-to-operate assessments.
- Innovators should assess the patent’s claims scope for potential licensing or collaboration.
Conclusion
Patent RU2007102578 exemplifies pharmaceutical patent protection in Russia, with claims likely covering novel compounds and methods relevant to therapeutic applications. Its scope appears appropriately broad yet well-defined, aligning with Russian and international patent standards. The patent landscape in Russia continues to evolve, emphasizing the importance of proactive patent strategies, comprehensive prior art searches, and vigilant monitoring of legal status.
Key Takeaways
- RU2007102578 offers substantive protection for a specific pharmaceutical invention, potentially covering innovative compounds or methods.
- The scope of claims influences enforceability and market exclusivity; clear, well-supported claims are vital.
- The Russian drug patent landscape favors robust, inventive, and novel pharmaceutical patents, but challenges and competition persist.
- Stakeholders should continuously monitor patent status, expiration timelines, and emerging filings to inform R&D and commercialization strategies.
- Licensing, infringement management, and strategic patenting remain critical in maximizing the value of this patent.
FAQs
1. What types of inventions does RU2007102578 protect?
It primarily protects novel chemical compounds, formulations, or specific methods of production or use related to pharmaceutical applications.
2. How does Russian patent law affect the scope of the claims?
Russian patent law emphasizes novelty, inventive step, and industrial applicability, influencing how broad or narrow claims can be constructed and enforced.
3. Can this patent be challenged or invalidated?
Yes, through post-grant procedures such as opposition or invalidation based on prior art or procedural deficiencies.
4. What is the typical lifespan of this patent?
In Russia, pharmaceutical patents generally last 20 years from the filing date, subject to annual maintenance fees.
5. How does this patent landscape compare with international standards?
Russian patent standards align with TRIPS, emphasizing clear, inventive, and novel claims comparable to European or US pharmaceutical patents.
Sources:
[1] Russian Federal Service for Intellectual Property (ROSPATENT). Official patent database and legal framework information.
[2] World Intellectual Property Organization (WIPO). Patent data and global legislation on pharmaceutical patents.
[3] Russian Civil Code, Part IV. Patent Law Regulations.
